MALAT1 and hepatocellular carcinoma: They observed that siRNA knockdown of MALAT1 reduced cell proliferation and repressed migration and invasion as well as apoptosis, indicating that blocking MALAT1 activity in HCC might be a vital anticancer therapy [90].